Skip to content
TrialScanner

NCT05378386

ALTERRA Post-Approval Study

No phase registeredActive, not recruitingEWLead

Registry record

Lead sponsor
Edwards Lifesciences
Conditions
Pulmonary Valve Insufficiency; Complex Congenital Heart Defect; Tetralogy of Fallot; Pulmonary Regurgitation; RVOT Anomaly
Primary completion
Sep 25, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05378386 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05378386: ALTERRA Post-Approval Study | TrialScanner